Skip to content
香港聯合腫瘤中心
  • Cancer diagnosis
    • Physical examination
      • Male/Female physical examination plan
    • Endoscopic examination
    • X-ray
    • Ultrasound examination
    • Laboratory examination
    • Cytological examination
    • Pathological diagnosis
    • Positron emission tomography and computed tomography (PET/CT)
    • Magnetic resonance imaging (MRI)
    • Computed tomography (CT) scan
    • Genetic testing
  • Cancer treatment
    • Information for newly diagnosed patients
    • Surgery
    • Radiotherapy
    • Chemotherapy
      • Side Effect
      • Chemotherapy Instructions
      • cancer cell characteristics, and individual constitution.
    • Gene-directed targeted therapy
    • Targeted therapy
    • Hormone therapy
    • Immunotherapy
    • Hyperbaric oxygen therapy
      • Sudden hearing loss
      • Ischemic stroke / Cerebral stroke
      • Diabetic foot ulcers
      • Applications in oncology
  • Types of cancer
    • What is cancer
    • breast cancer
    • Lung cancer
      • Lung cancer articles and reports
    • colorectal cancer
    • liver cancer
    • stomach cancer
    • prostate cancer
    • thyroid cancer
    • brain cancer
    • nasopharyngeal cancer
    • cervical cancer
    • pancreatic cancer
    • Uterine body cancer
  • Cancer information
    • New cancer drugs
      • Lung cancer drugs
      • Breast cancer drugs
      • Bile duct cancer drugs
      • Liver cancer drugs
      • Bowel cancer drugs
      • Urothelial carcinoma drugs
      • Prostate cancer drugs
    • News report
    • Cancer information video
    • Medical lectures
    • Doctor Q&A
  • Clinical research
  • Contact us
    • Contact methods
    • Join us
  • 繁
  • En
  • Cancer diagnosis
    • Physical examination
      • Male/Female physical examination plan
    • Endoscopic examination
    • X-ray
    • Ultrasound examination
    • Laboratory examination
    • Cytological examination
    • Pathological diagnosis
    • Positron emission tomography and computed tomography (PET/CT)
    • Magnetic resonance imaging (MRI)
    • Computed tomography (CT) scan
    • Genetic testing
  • Cancer treatment
    • Information for newly diagnosed patients
    • Surgery
    • Radiotherapy
    • Chemotherapy
      • Side Effect
      • Chemotherapy Instructions
      • cancer cell characteristics, and individual constitution.
    • Gene-directed targeted therapy
    • Targeted therapy
    • Hormone therapy
    • Immunotherapy
    • Hyperbaric oxygen therapy
      • Sudden hearing loss
      • Ischemic stroke / Cerebral stroke
      • Diabetic foot ulcers
      • Applications in oncology
  • Types of cancer
    • What is cancer
    • breast cancer
    • Lung cancer
      • Lung cancer articles and reports
    • colorectal cancer
    • liver cancer
    • stomach cancer
    • prostate cancer
    • thyroid cancer
    • brain cancer
    • nasopharyngeal cancer
    • cervical cancer
    • pancreatic cancer
    • Uterine body cancer
  • Cancer information
    • New cancer drugs
      • Lung cancer drugs
      • Breast cancer drugs
      • Bile duct cancer drugs
      • Liver cancer drugs
      • Bowel cancer drugs
      • Urothelial carcinoma drugs
      • Prostate cancer drugs
    • News report
    • Cancer information video
    • Medical lectures
    • Doctor Q&A
  • Clinical research
  • Contact us
    • Contact methods
    • Join us
  • 繁
  • En

Category: 乳癌

260908 甲狀腺癌_肺癌_乳癌治療新趨勢_8Sep2026保誠保險

甲狀腺癌・肺癌・乳癌治療新趨勢｜患者指南（保誠保險講座摘錄）

癌症治療已全面邁入「精準醫療」時代。香港聯合腫瘤中心李宇聰醫生於保誠保險專場講座中，系統性地介紹了甲狀腺癌、肺癌與乳癌的最新診斷、基因檢測、標靶、免疫

立即閱讀
2026 年 9 月 17 日 No Comments
15/8廣華醫院乳癌病人妍進會講座

乳癌現代治療策略與營養支持全攻略：從個人化診斷、術前治療資源到抗癌飲食管理｜癌症講座系列（2026/08/15）

日期：2026年8月15日 | 地點：廣華醫院徐展堂大樓 6/F | 主講：臨床腫瘤科專科醫生李宇聰醫生 講座背景 乳癌高居香港女

立即閱讀
2026 年 9 月 1 日 No Comments
am730_健康解碼｜HER2陽性乳癌擴散快、侵略性高 醫生籲早求醫_04Aug2026

健康解碼｜HER2陽性乳癌擴散快、侵略性高 醫生籲早求醫 (am730：04/08/2026)

【乳癌健康解碼】HER2陽性乳癌擴散快、侵略性高？臨床腫瘤科專科醫生李宇聰拆解高危因素、最新二線治療與個人化方案 乳癌是本港女性頭號常見癌症。隨著大眾

立即閱讀
2026 年 8 月 14 日 No Comments

肺癌・乳癌・淋巴瘤治療新趨勢｜患者指南（Manulife 內部分享摘錄）

2026年8月3日，香港聯合腫瘤中心（HKUOC）臨床腫瘤科專科醫生李宇聰醫生，應邀於 Manulife（宏利）健康講座中，深入分享了肺癌、乳癌及淋巴

立即閱讀
2026 年 8 月 5 日 No Comments
Phase 3 randomized, double-blind study in first-line ER+ (≥1%), HER2− advanced/metastatic breast cancer comparing palazestrant + ribociclib vs letrozole + ribociclib. Includes key inclusion/exclusion criteria and dosing details. Contact Hong Kong United Oncology Centre.

NCT07085767: OPERA-02 Study

The Hong Kong United Oncology Centre is currently conducting an international Phase III clinical trial. If you are a patient with estrogen receptor-positive (ER+), HER2-negative (HER2−) advanced/metastatic breast cancer, please contact us. We will conduct an initial assessment to determine if you meet the eligibility criteria for this clinical trial. Medication and imaging scan costs are fully covered. However, patients must understand the purpose of the study and the potential risks involved.

立即閱讀
December 18, 2025 No Comments
李宇聰醫生主講「擁抱希望 - 早期乳癌新認知」講座 | 全球華人乳癌組織聯盟 GCBC × 香港聯合腫瘤中心 HKUOC | 2025年10月31日

Dr. Li Yu Chung, Jacky will present a lecture titled "Embracing Hope – New Understanding of Early Breast Cancer" | Global Chinese Breast Cancer Organization Alliance (GCBC) × HKUOC | October 31, 2025

2025年10月31日（星期五），香港聯合腫瘤中心（HKUOC）臨床腫瘤科李宇聰醫生應邀在全球華人乳癌組織聯盟（GCBC）的患者教育講座中，分享早期乳

立即閱讀
December 2, 2025 No Comments
2025年9月18日 宏利健康講座：肺癌、乳癌及前列腺癌治療新趨勢 - 香港聯合腫瘤中心李宇聰醫生分享

Manulife Health Seminar, September 18, 2025: New Trends in the Treatment of Lung Cancer, Breast Cancer, and Prostate Cancer – Dr. Li Yu-chung of the Hong Kong United Oncology Centre shares his insights.

On September 18, 2025, Dr. Li Yu Chung, Jacky of the Department of Clinical Oncology at the Hong Kong United Oncology Centre (HKUOC) will share the latest treatment trends in lung cancer, breast cancer, and prostate cancer at the Manulife Health Seminar. The seminar will be held at Manulife Tower in Kwun Tong from 10:30 a.m. to 11:30 a.m. All are welcome to attend and learn about the cutting-edge treatment technologies and personalized plans!

立即閱讀
December 1, 2025 No Comments

NCT06966700: Trofuse-032/MK2870-032 Research

Hong Kong United Oncology Centre is currently conducting an international Phase III clinical trial. If you are a patient with high-risk early-stage triple-negative breast cancer (TNBC) or hormone receptor-weak positive/HER2-negative breast cancer, please contact us. We will conduct an initial assessment to determine if you meet the criteria for participation in this clinical trial. Medication and imaging scan costs are fully covered. However, patients must understand the purpose of the study and the potential risks involved.

立即閱讀
November 19, 2025 No Comments
2025年肺癌治療新趨勢 - 李宇聰醫生於AIA講座分享

New trends in the treatment of lung cancer, breast cancer, and prostate cancer｜Patient Guide (Excerpted from AIA Internal Sharing｜2025/07/30)

2025年7月30日，香港聯合腫瘤中心（HKUOC）李宇聰醫生於AIA健康教育分享會講解肺癌、乳癌、前列腺癌治療新趨勢。包括標靶治療、免疫治療、ADC、SBRT及177Lu-PSMA等最新技術，僅供教育參考，助患者了解就醫重點與個人化治療方案。

立即閱讀
August 12, 2025 No Comments

Oral SERD drugs will change the pattern of hormone receptor-positive breast cancer treatment

口服SERD藥物將改變荷爾蒙受體陽性乳腺癌治療格局 雌激素受體抑制 雖是荷爾蒙受體陽性乳腺癌的有效治療手段，但傳統內分泌治療存在 藥代動力學限制 和

立即閱讀
July 4, 2025 No Comments
Page1 Page2 Page3 Page4 Page5
香港聯合腫瘤中心

The Hong Kong United Oncology Centre (HKUOC) provides cancer-related medical services such as cancer screening, cancer diagnosis and cancer treatment, including immunotherapy, chemotherapy, targeted drug therapy, radiation therapy, hormone therapy and palliative care.

Contact us

  • Address: Rooms 01-06, 20/F, 238 Nathan Road, Kowloon (MTR Jordan Station Exit E)
  • Phone: +852 2386 8002
  • WhatsApp：5518 2992
  • Fax: (852) 2386 8229
  • Macau: Enquiry@hkuoc.hk

Consultation time

Monday to Friday

9:00 am to 1:00 pm

2:00 p.m. to 6:00 p.m.

Saturday

9:00 am to 1:00 pm

Closed on Sundays and public holidays

Types of cancer

  • breast cancer
  • Lung cancer
  • colorectal cancer
  • liver cancer
  • stomach cancer
  • prostate cancer
  • thyroid cancer
  • brain cancer
  • nasopharyngeal cancer
  • pancreatic cancer
  • Uterine body cancer
  • breast cancer
  • Lung cancer
  • colorectal cancer
  • liver cancer
  • stomach cancer
  • prostate cancer
  • thyroid cancer
  • brain cancer
  • nasopharyngeal cancer
  • pancreatic cancer
  • Uterine body cancer

Cancer treatment

  • Information for newly diagnosed patients
  • Surgery
  • Radiation therapy (electrotherapy)
  • Chemotherapy
  • Targeted therapy
  • Hormone therapy
  • Immunotherapy
  • Information for newly diagnosed patients
  • Surgery
  • Radiation therapy (electrotherapy)
  • Chemotherapy
  • Targeted therapy
  • Hormone therapy
  • Immunotherapy

phone

WhatsApp

Facebook